Pharmaceutical

Syros Pharmaceuticals gets grant for CDK7 inhibitors for treating cancer and other diseases

Discover how Syros Pharmaceuticals' patented compounds inhibit CDK7, inducing cellular apoptosis and treating diseases like cancer and ALS.

Jun 12, 2024 - 04:00
Syros Pharmaceuticals gets grant for CDK7 inhibitors for treating cancer and other diseases
Discover how Syros Pharmaceuticals' patented compounds inhibit CDK7, inducing cellular apoptosis and treating diseases like cancer and ALS.
Read the original article

Tags:

Previous Article

Silence Therapeutics gets grant for compound for rna interference therapy in tre...

Next Article

United Laboratories International gets grant for method for removing contaminant...

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Breast cancer screening should begin at 40, not 50, federal health panel recommends

Breast cancer screening should begin at 40, not 50, fed...

May 9, 2023

STAT+: Tough road ahead for Bluebird Bio despite FDA approval for sickle cell therapy

STAT+: Tough road ahead for Bluebird Bio despite FDA ap...

Dec 9, 2023

STAT+: To make immunotherapy safe for brain tumors, researchers will have to tackle new risks

STAT+: To make immunotherapy safe for brain tumors, res...

Apr 7, 2023